Cargando…

New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review

The ravages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide have sped up the development of relevant vaccines, which is accompanied by public concerns over possible adverse effects. We report a rare case of a 39-year-old woman who suffered from severe hyperglycemia and keto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Lanhui, Liang, Min, He, Yuling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279518/ https://www.ncbi.nlm.nih.gov/pubmed/37337812 http://dx.doi.org/10.3346/jkms.2023.38.e209

Ejemplares similares

New-Onset Fulminant Type 1 Diabetes After SARS-CoV-2 Infection
por: Pan, Yunfei, et al.
Publicado: (2023)

SARS-CoV-2 Fulminant Myocarditis
por: Garot, Jérôme, et al.
Publicado: (2020)

Fulminant Type 1 Diabetes Mellitus after SARS-CoV-2 Vaccination: A Case Report
por: Lin, Rong, et al.
Publicado: (2022)

Fulminant myocarditis as an early presentation of SARS-CoV-2
por: Naneishvili, Tamara, et al.
Publicado: (2020)

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022)

Fulminant Myocarditis Following SARS-CoV-2 Infection: JACC Patient Care Pathways
por: Rajpal, Saurabh, et al.
Publicado: (2022)

Fulminant Clostridioides difficile Colitis With SARS-CoV-2 Infection
por: Duhan, Sanchit, et al.
Publicado: (2023)

Case report: Fulminant type 1 diabetes following paucisymptomatic SARS-CoV-2 infection during late pregnancy
por: Zhou, Lingling, et al.
Publicado: (2023)

Fulminant fungal endogenous endophthalmitis following SARS-CoV-2 infection: A case report
por: Jain, Mukesh, et al.
Publicado: (2022)

Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection()
por: Lozano Gómez, Herminia, et al.
Publicado: (2020)

SARS-CoV-2: a potential novel etiology of fulminant myocarditis
por: Chen, Chen, et al.
Publicado: (2020)

Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination
por: Gorman, Matthew J., et al.
Publicado: (2021)

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
por: Sun, Yi-Sheng, et al.
Publicado: (2021)

Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine
por: Elder, Elizabeth, et al.
Publicado: (2023)

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
por: Zhang, Rong, et al.
Publicado: (2022)

Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes
por: Nishino, Kohei, et al.
Publicado: (2022)

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
por: Alter, Galit, et al.
Publicado: (2021)

Fulminant Myocarditis After SARS-CoV-2 mRNA Vaccine Successfully Managed With Biventricular Impella Support: Multimodality Imaging Follow-Up
por: Ching, Shing, et al.
Publicado: (2022)

Establishment of the first Chinese national standard for protein subunit SARS-CoV-2 vaccine
por: Gao, Fan, et al.
Publicado: (2022)

Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine
por: Peng, Hua, et al.
Publicado: (2022)

Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
por: Shi, Juan, et al.
Publicado: (2023)

POS-134 NEW ONSET NEPHROTIC SYNDROME FOLLOWING INACTIVATED SARS-CoV-2 VACCINE
por: Lim, Y.S., et al.
Publicado: (2022)

Clinical features of patients with new onset of autoimmune hepatitis following SARS-CoV-2 vaccination
por: Rigamonti, C., et al.
Publicado: (2022)

New-onset Graves’ disease following SARS-CoV-2 vaccination: a case report
por: Manta, Ringo, et al.
Publicado: (2022)

A Case of Isolated SARS-CoV-2 Fulminant Myopericarditis Without Respiratory Failure
por: Afriyie, Felix, et al.
Publicado: (2021)

Fulminant Myocarditis With ST Elevation and Cardiogenic Shock in a SARS-CoV-2 Patient
por: Ghafoor, Khuzema, et al.
Publicado: (2021)

Fulminant Encephalitis Caused by SARS-CoV-2 in a Two-Month-Old Infant
por: Abdelbari, Marwa, et al.
Publicado: (2022)

The protective nasal boosting of a triple-RBD subunit vaccine against SARS-CoV-2 following inactivated virus vaccination
por: Yang, Jingyi, et al.
Publicado: (2023)

Development of an ELISA Assay for the Determination of SARS-CoV-2 Protein Subunit Vaccine Antigen Content
por: Han, Lu, et al.
Publicado: (2022)

Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M(™) vaccination
por: Gorman, Matthew J, et al.
Publicado: (2021)

Syncope at SARS-CoV-2 onset
por: Canetta, Ciro, et al.
Publicado: (2020)

New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster
por: Arismendez, Alan A., et al.
Publicado: (2023)

New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review
por: Holzer, Marie-Therese, et al.
Publicado: (2022)

Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination
por: Showers, Christopher R, et al.
Publicado: (2022)

Vigilance on New-Onset Atherosclerosis Following SARS-CoV-2 Infection
por: Liu, Ya, et al.
Publicado: (2021)

Fulminant Encephalitis Caused by SARS-CoV-2 in a Two-Month-Old Infant: Correspondence
por: Finsterer, Josef
Publicado: (2023)

Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
por: Castaldo, Matteo, et al.
Publicado: (2022)

SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature
por: Ramdas, Sithara, et al.
Publicado: (2022)

New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review
por: Nakazawa, Eriko, et al.
Publicado: (2021)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sileg2pn0tb1t9lerk4he3bthu